NCT06123663View on ClinicalTrials.gov

A Study to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 20, 2023

Primary Completion Date

January 23, 2024

Study Completion Date

June 18, 2024

Conditions
Tetanus
Interventions
BIOLOGICAL

TTVA

Intramuscular injection, 1 dose of 0.5ml inoculated on Day 0

BIOLOGICAL

TT

Intramuscular injection, 1 dose of 0.5ml inoculated on Day 0

Trial Locations (1)

Unknown

Center for Disease Control and Prevention, Qixingguan District, Bijie City, Bijie

Sponsors
All Listed Sponsors
lead

CanSino Biologics Inc.

INDUSTRY

NCT06123663 - A Study to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over | Biotech Hunter | Biotech Hunter